Harnessing the Immune System to Fight Disease

Broad Immunotherapy Reach


Advancing first-in-class immunotherapy product candidates in oncology, as well as infectious and allergic diseases.


Immune Design is a late-stage immunotherapy company employing next-generation in vivo approaches to enable the body’s immune system to fight disease. The company’s technologies are engineered to activate the immune system’s natural ability to generate and/or expand antigen-specific cytotoxic immune cells to fight cancer and other chronic diseases.


We leverage our cutting-edge platforms to produce product candidates and utilize distinct therapeutic approaches that, we believe, address the shortcomings of existing therapies and have the potential to treat a broad patient population either as individual therapies or in combination with other mechanisms of action. Our primary product candidate, G100, is in clinical trials intended to lead to eventual registration, data dependent.
Read More

Infectious and allergic DISEASES

ZVex® and GLAAS® -based products have potential therapeutic utility outside of oncology and provide an opportunity for an innovative approach to develop improved therapeutics. We have been successfully executing a strategy to partner individual indications outside of oncology in infectious and allergic diseases, which provide potential downstream economics while preserving growth opportunity in the future.
(see partners)
Read More